InvestorsHub Logo
Followers 9
Posts 402
Boards Moderated 0
Alias Born 04/22/2013

Re: Bobbyinvest post# 24008

Tuesday, 06/26/2018 11:56:42 PM

Tuesday, June 26, 2018 11:56:42 PM

Post# of 233151
Bobby:
I spoke with Jody Cain at length today as a representative of our smallish investment group. Our primary concerns are the course management will take with regards to raising capital on friendlier terms, detailed explanations on what the "various/numerous" issues are required to be addressed to satisfy FDA questions, explanation of the "severe & serious" SAE's on the recent ASM poster - and when the next conference call could be expected.

This was my fifth or sixth conversation with Jody and as before I found her to be as open and engaging as policies allow. She shared she's had a number of calls ( more than usual) from shareholders voicing similar concerns and while not in the position to give concrete answers did say their is a scheduled conference call " not far off" or "near term" to lay it all on the line with shareholders.

She also said that one part of her job is take these calls/questions and forward them to management so they can be addressed at the conference. She's the senior vice president of the health care division and knows her stuff- from science to fund raising.

Also as before I voiced our displeasure that management hasn't ( or won't) consider up listing to the NYSE- for which I contend they have one path of eligibility - and she didn't dispute that notion- In any event, today was a great news day and hopefully we'll have an audience with management very soon - GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News